Avandia: Should It Have Been Voted Down and Withdrawn?

category: Dafé’s Café - Daily Dose of Medical News,MyDocHub
by Dafé,

With 12 of the 33 members voted to withdraw Avandia from the market, and 20 voted to let the drug remain on the market with enhanced restrictions and rigorous black box warning labels, it shows that Avandia’s manufacturer, Glaxo Smith Kline, did not provide enough research to vote either way.

In light of that, the questions is did Glaxo Smith Kline intentionally provide ambiguous research data to confuse the 33 members and hence increase its chance of getting enough votes? And should Avandia be taking off the market by the FDA regardless of the recommendations of the 33 members?

However, the panel found that Avandia does increase the risk of heart problems compared to other diabetes medications.

Comments

1 Comment so far

Twitter Trackbacks for Avandia: Should It Have Been Voted Down and Withdrawn? | MyDocHub Blog - Online Health Community [mydochub.com] on Topsy.com | 15 July 2010, 11:23
[...] Avandia: Should It Have Been Voted Down and Withdrawn? | MyDocHub Blog – Online Health Community mydochub.com/blog/index.php/2010/07/15/avandia-should-it-have-been-voted-down-and-withdrawn/ – view page – cached Learn about the issues facing diabetes drug Avandia and why it was almost withdrawn from the market because of its risk of heart attack by the FDA., Learn about the issues facing diabetes drug Avandia and why it was almost withdrawn from the market because of its … Tweets about this link [...]